《Lancet Gastroenterology & Hepatology》重点专注发布Medicine-Hepatology领域的新研究,旨在促进和传播该领域相关的新技术和新知识。鼓励该领域研究者详细地发表他们的高质量实验研究和理论结果。根据网友分享的投稿经验,平均审稿速度为 。该杂志创刊至今,在Medicine-Hepatology领域,影响力非凡,对来稿文章质量要求很高,稿件投稿过审难度很大,刊登文章的学术水平和编辑质量在同类杂志中均名列前茅。如果你想在该杂志上发表论文,你可以向编辑部提交文章,但文章必须具有重要意义并代表该领域专业的发展。我们欢迎广大同领域的研究者提交投稿。
CiteScore | SJR | SNIP | CiteScore排名 | |||
---|---|---|---|---|---|---|
50.3 | 8.957 | 8.086 | 学科类别 | 分区 | 排名 | 百分位 |
大类:大类:Medicine
小类:小类:Gastroenterology
|
Q1 | 2/167 | 99% | |||
大类:大类:Medicine
小类:小类:Hepatology
|
Q1 | 2/82 | 98% |
按JIF指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
---|---|---|---|---|
学科:GASTROENTEROLOGY & HEPATOLOGY | SCIE | Q1 | 2 / 143 | 99% |
按JCI指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
---|---|---|---|---|
学科:GASTROENTEROLOGY & HEPATOLOGY | SCIE | Q1 | 2 / 143 | 98.95% |
文章名称
引用次数
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study
179
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
84
Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial
78
Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis
72
Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohns disease: a prospective, multicentre, cohort study
58
A global scientific strategy to cure hepatitis B
54
Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial
53
Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase multicentre trial
48
Direct-acting antiviral treatment for hepatitis C among people who use or inject drugs: a systematic review and meta-analysis
44
The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
40
国家/地区
发文量
TUSA
177
TEngland
161
TCHINA MAINLAND
65
TItaly
56
TAustralia
54
TFrance
54
TCanada
53
TNetherlands
49
TGERMANY (FED REP GER)
46
TSpain
36





